At a glance
ClinicalIndex Comparison RecordN/ACompleted· 106 enrolled
Drug / intervention
Masimo Noninvasive Blood Pressure Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of Noninvasive Blood Pressure Device
In Brief
A clinical study evaluating Masimo Noninvasive Blood Pressure Device for Healthy and 2 related conditions. Completed, enrolled 106 participants across 2 sites.
Detailed Summary
This is a prospective, nonrandomized multi-center study for the investigation of noninvasive sphygmomanometers. The purpose of the study is to validate the clinical performance of the Masimo noninvasive blood pressure device compared to reference auscultatory measurements.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Hypertension, Hypotension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartOct 2020
Primary CompletionNov 2020
First PostedDec 2020
TodayJul 2026
First PostedDec 19, 2020
Enrollment StartOct 5, 2020
Primary CompletionNov 2, 2020
TodayJul 2, 2026
Enrollment to primary: 27 daysPosted 5.5 years ago
Interventions
Masimo Noninvasive Blood Pressure Devicedevice
Non-invasive blood pressure device